Age-related thickening and narrowing of the aortic valve that restricts blood flow and forces the heart to work harder.
TAVR / TAVI Treatment
TAVR (Transcatheter Aortic Valve Replacement), also known as TAVI, is an advanced treatment for severe aortic valve stenosis, in which the aortic valve becomes thickened and narrowed, restricting blood flow from the heart to the rest of the body. It offers a minimally invasive alternative to open-heart aortic valve surgery, particularly for elderly and high-risk patients.
Patient suitability is determined after detailed clinical examination, imaging and evaluation of the individual patient’s heart and blood vessel anatomy.
Conditions treated with TAVR / TAVI
A congenital valve variation with two leaflets instead of three, which can narrow prematurely and may require specialised TAVR planning.
A previously implanted surgical valve that has worn out over time, treatable with valve-in-valve TAVR.
Patients whose age or co-existing illnesses make conventional open-heart valve surgery unsafe, so TAVR may be considered after Heart Team evaluation.
How the TAVR / TAVI procedure is performed
In TAVR, a new, collapsible artificial valve is delivered on a catheter, usually through the femoral artery in the groin, and expanded precisely inside the diseased native aortic valve. The new valve immediately takes over the job of regulating blood flow, without the need to open the chest or stop the heart, as required in conventional surgical valve replacement.
The procedure is performed in a cardiac catheterisation laboratory. Continuous imaging allows accurate positioning of the device and assessment of the result before completion.
Benefits of TAVR / TAVI
- No open-heart surgery, chest incision or heart-lung machine required in most cases
- Shorter hospital stay compared to surgical aortic valve replacement
- Faster relief from breathlessness, chest discomfort and fatigue
- May carry a lower procedural risk than open surgery in selected elderly and high-risk patients
- Long-term valve durability is still being studied, so regular follow-up is advised
- Suitable for complex cases including bicuspid valve and valve-in-valve TAVR
Risks and limitations of TAVR / TAVI
- Bleeding or injury to the blood vessel at the puncture site
- Stroke
- Kidney injury related to contrast dye
- Irregular heart rhythm or heart block, which may need a permanent pacemaker
- Leakage around the new valve
- Problems with valve position
- Infection
- Rarely, emergency open-heart surgery or death
- TAVR may not be suitable for every patient
- Long-term durability of transcatheter valves is still being studied
- Individual risks depend on age, other medical conditions and the anatomy of the heart and blood vessels. Your doctor will explain your individual risks before the procedure.
Every procedure carries some risk. Your cardiologist will explain the risks relevant to your condition before the procedure.
Recovery after the procedure
Recovery after TAVR is generally quick, with most patients mobile within 24 hours and discharged within two to four days. Regular follow-up with echocardiography is advised to monitor valve function, along with guideline-directed medication for long-term heart health.
Medication instructions and follow-up schedules should be followed carefully. Contact the treating doctor immediately in case of unusual pain, bleeding, swelling, fever or breathing difficulty.